High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
Saved in:
| Title: | High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. |
|---|---|
| Authors: | McGrail, D.J.1 djmcgrail@mdanderson.org, Pilié, P.G.2, Rashid, N.U.3,4, Voorwerk, L.5, Slagter, M.6,7,8, Kok, M.5,9, Jonasch, E.2, Khasraw, M.10, Heimberger, A.B.11, Lim, B.12, Ueno, N.T.12, Litton, J.K.12, Ferrarotto, R.13, Chang, J.T.14,15, Moulder, S.L.12, Lin, S.-Y.1 sylin@mdanderson.org |
| Source: | Annals of Oncology. May2021, Vol. 32 Issue 5, p661-672. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.02.006 |
